Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canicola fever; case report and review of the literature.

Archives of internal medicine (Chicago, Ill. : 1908)·2010
Same author

Kiss and tell: what do we know about pre- and early adolescent females who report dating? A pilot study.

Journal of pediatric and adolescent gynecology·2007
Same author

Right hilar pseudomass due to partial right lower lobe atelectasis.

Journal of thoracic imaging·2001
Same author

CT halo sign in pulmonary metastases from mucinous adenocarcinoma of the pancreas.

Southern medical journal·2001
Same author

Pleural effusion is a cause of round atelectasis of the lung.

The Journal of the Kentucky Medical Association·2001
Same author

Sonographic features of primary breast cancer in men.

AJR. American journal of roentgenology·2001

Related Experiment Video

Updated: Jul 21, 2026

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
08:27

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury

Published on: May 21, 2018

Salicylate-induced pulmonary edema.

J S Walters, J H Woodring, C B Stelling

    Radiology
    |February 1, 1983
    PubMed
    Summary

    Salicylate intoxication can cause noncardiogenic pulmonary edema in patients over 30. Risk factors like smoking and acidosis increase this risk, which is otherwise rare.

    Area of Science:

    • Pulmonary Medicine
    • Toxicology

    Background:

    • Noncardiogenic pulmonary edema is a serious complication of salicylate intoxication.
    • It affects a significant percentage of older patients with salicylate toxicity.

    Purpose of the Study:

    • To identify risk factors for salicylate-induced pulmonary edema.
    • To understand the prevalence and etiology of this condition.

    Main Methods:

    • Retrospective analysis of patients with salicylate intoxication.
    • Identification of demographic and clinical risk factors.

    Main Results:

    • Pulmonary edema occurred in 35% of patients over 30 years old.
    • Key risk factors included cigarette smoking, chronic salicylate use, metabolic acidosis, and neurological symptoms.

    More Related Videos

    A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
    07:40

    A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

    Published on: August 30, 2019

    Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
    04:45

    Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

    Published on: June 2, 2022

    Related Experiment Videos

    Last Updated: Jul 21, 2026

    Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
    08:27

    Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury

    Published on: May 21, 2018

    A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
    07:40

    A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

    Published on: August 30, 2019

    Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
    04:45

    Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

    Published on: June 2, 2022

  • The condition is rare without these identified risk factors.

    • Conclusions:

    • Salicylate-induced pulmonary edema is multifactorial, primarily involving increased pulmonary vascular permeability.
    • Specific risk factors significantly elevate the likelihood of developing pulmonary edema in salicylate-intoxicated patients over 30.